跳至主要内容
临床试验/ISRCTN66284161
ISRCTN66284161已完成未知

A placebo-controlled trial of nimodipine with cyclophosphamide/cisplatin for the treatment of advanced ovarian cancer

Cancer Research UK (CRUK) (UK)0 个研究点目标入组 0 人开始时间: 2001年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Confirmed diagnosis of invasive epithelial ovarian cancer
  • 2. International Federation of Gynaecology and Obstetrics (FIGO) stages Tc - Tv
  • 3. 18-70 years old
  • 4. Performance Status less than or equal to 2
  • 5. White Blood Cells at least 4 x 10^9/l
  • 6. Platelets at least 120 x 10^9/l
  • 7. Creatinine or Ethylene Diamine Tetraacetic Acid (EDTA) clearance greater than or equal to 60 ml/min
  • 8. Normal Bilirubin
  • 9. Serum glutamic-oxaloacetic transaminase (SGOT)/Serum glutamic pyruvic transaminase (SGPT) less than or equal to twice normal limit
  • 10. No previous chemotherapy or radiotherapy

排除标准

  • Not provided at time of registration

研究者

发起方
Cancer Research UK (CRUK) (UK)

相似试验